Review on: Pharmacological Activity of Caterpilllar fungus (Keeda Jadi)
DOI:
https://doi.org/10.55544/jrasb.2.3.17Keywords:
Caterpillar fungus (Keeda jari), Pharmacological role, Traditional usesAbstract
In this review we focus about the pharmacology, biological characteristics and therapeutic uses of Caterpillar fungus (Keeda jari) which is also known as keeda ghaas, Yarsa gamba. It is found at high Himalayan mountains of India, Nepal and Tibet. It is found between 3500 and 5000 meters above sea level. It is an entomo-fungal combination of a larva of small moth, Hepialus armoricanus and a parasite fungus Cordyceps sinensis. Cordyceps is best known medicine for increasing physical stamina and sexual functions. It has been proven to improve liver, kidney, and lung functioning in addition to being routinely used to treat people with heart disease. Numerous investigations have shown that it possesses a wide range of biological functions and pharmacological potential despite not being harvested in a sustainable or deliberate manner.
Downloads
Metrics
References
Cordyceps sinensis: fungus populating the Himalayas and a source of income, Curr Sci, 103(8) (2012) 876, Bhandari A K, Negi J S, Bisht V K, Singh N, & Sundriyal R C.
Sharma, S., "Trade of Cordyceps sinensis from High Altitudes of the Indian Himalaya: Conservation and Biotechnological Priorities," Curr. Sci., 86 (2004) 1614–1619.
The scientific rediscovery of a priceless old Chinese herbal regimen: Cordyceps sinensis: Part II, J Alter Comple Med, 4 (1998) 429–457. Zhu, J. S., G. Halpern, & K. Jones.
Indian J. Traditional Knowledge, 3 (2004) 182-186. Garbyal S. S., Agarwal K. K., and Babu C. R. "Impact of Cordyceps sinensis in the rural economy of interior villages of Dharchula sub-division of Kumaon Himalayas and its implications in the society."
Conservation salvage of Cordyceps sinensis collection in the Himalayan mountains is ignored, Kuniyal C P & Sundriyal R C, Ecosys Serv, 3 (2013) 40–43. Yarsa gumba (Cordyceps sinensis): A call for its sustainable usage, Negi C. S., Koranga P. R., and Ghinga H.
13 (2006), 1–8 Int J Sust Dev World Ecol. Collection of Cordyceps sinensis (Berk.) Sacc. in the inner hamlet of Chamoli district in Garhwal Himalaya Uttarakhnd and its social consequences, J Am Sci, 6 (2010) 5-9. Singh N, Pathak R, Singh A, Rautela D, and Dubey A. Our Nature, 4 (2006) 48–52, Devkota S, Yarsagumba [Cordyceps sinensis (Berk.) Sacc.]; traditional use in Dolpa District, Western Nepal.
Winkler, D., "Yartsa Gunbu (Cordyceps sinensis) and the fungal commodification of Tibet's rural economy," Econ Bot, 62 (2008), 291-305.
Cordyceps sinensis' impact on cardiac and vascular function in renally hypertensive rats is described in Wu X X's study. Chinese Journal of Integrative Medicine, 3 (2005) 137–138.
Inhibitory impact of Cordyceps sinensis on experimental hepatic fibrosis and its potential mechanism, World J Gastroenterol, 9 (2003) 529-533. Liu Y. K. & Shen W.
Effects of corydyceps polysaccharide on liver fibrosis brought on by DMN in rats, Li F H, Liu P, Xiong W G & Xu G, 31 (2006), 1968-1971, Zhongguo Zhong Yao Za Zhi.
Li-Xia J, Song L, Si-Ming Y, Xiao-Peng M, and African J Pharm Pharmacol, 4 (2010) 471-478. The preventive effects of Cordyceps sinensis extract on extracellular matrix buildup of Glomerular sclerosis in rats.
Xu F, Huang J B, Jiang L, Xu J & Mi J, Amelioration of cyclosporin nephrotoxicity by Cordyceps sinensis in kidney transplanted recipients, Nephrol Dial Transplant, 10 (1995)142-143.
18 Guo T F & Guo T Y, Study on pharmacological action and clinical application of Cordyceps sinensis, J Jindongnan Teachers Coll, 21 (2000) 70-73.
19 Donohue J F, Recent advances in the treatment of asthma, Curr Opin Pulm Med, 2 (1996) 1-6.
20 Han S R, Experiences in treating patients of chronic bronchitis and pulmonary diseases with Cs-4 capsule (JinShuiBao), J Admin Trad Chin Med, 5 (Suppl) (1995) 33-34.
Song K, Cai W L, Qu Z Y, and Tang J. a study of the JinShuiBao capsule's therapeutic efficacy for the treatment of respiratory ailments, J Admin Trad Chin Med 5 (1995), pp. 29–30.
Guo Y Z, Fermented Cordyceps sinensis mycelia and JinShuBao capsule: Medicinal Chemistry, Pharmacology, and Clinical Applications, J Modern Diag Ther 1, 60–65 (1986).
Appl Microbiol Biotechnol, 60 (2002) 258–274, Wasser S. P. Medicinal mushrooms as a source of anticancer and immunomodulating polysaccharides.
Ye M, Xia L, Tu W, Li L, and Zou G. Hu Z. Purification and analysis of an antibacterial protein from Cordyceps sinensis cultured mycelia. 709–714 in Wuhan Univ J Nat Sci, 11 (2006).
The fruiting body and its host of Cordyceps sinensis exhibit similar resemblance in major ingredients and anti-oxidation activities, according to Li S P, Su Z R, Dond T T, and Tsim K W. 319-324 in Phytomedicine, 9, 2002.
Shinozuka K, Kunitomo M, Kagota S, Yamaguchi Y, Nakamura K, Cordyceps sinensis oral treatment activates Kupffer cell activity in vivo in rats, Jpn. J. Pharmacol. 79 (1999): 505–508.
Advances in research on Cordyceps sinensis' anti-tumor properties, He J C & Zhang Y H, Chin J Tradit West Med 7, 2144–2147 (2006).
Studies on the components and pharmacological effect of polysaccharide from Cordyceps sinensis, Food Drug, 7 (2005) 45–48, by Yuan J. G., Cheng X. H., and Hou Y. Q.
Nyarko, R. O., & Kahwa, I. (2020). Attitude of Health Workers (Nurses) towards Patients and the Perception Patients have about Them: A Case Study at Kropa Health Centre in Ghana. Electronic Research Journal of Social Sciences and Humanities, 2(2), 203-210.
PASWAN, S. K., DHARMENDRA AHUJA, D. L., KUMAR, S., MUZTABA, M., AHMAD, A., SELVAKUMAR, P., ... & KUMAR, R. (2023). Volatile Alkaloids And Brain Disorder Investigation Of The Cognitive And Mood Effects Of Zingiber Officinale Essential Oil With In Vitro Properties Relevant To Central Nervous System Function. Journal of Pharmaceutical Negative Results, 574-589.
Kashyap, N., Kumar, R., Rana, V., Sood, P., & Chauhan, T. (2023). Role of Terpenoids Active Ingredients Targeting for Neuroprotective Agents. Journal for Research in Applied Sciences and Biotechnology, 2(3), 22-40.
Raj, R., Kumar, A., Sood, P., Kumar, R., & Rana, V. (2023). Randomized Phase III Trial Comparing Epirubicin/Doxorubicin Plus Docetaxel and Epirubicin/Doxorubicin Plus Paclitaxel as First Line Treatment in Women with Advanced Breast Cancer. Journal for Research in Applied Sciences and Biotechnology, 2(3), 55-63.
Antitumor sterols from the mycelia of Cordyceps sinensis, Bok J W, Lermer L, Chilton J, Klingeman H G, & Towers G H N, Phytochemistry, 51, 891-898 (1999).
Hu Z D, Zhang Q X, Leung P H, Wu J Y, Comparison of the anticancer effects of extracts from the naturally occurring Cordyceps sinensis and the farmed Cordyceps sinensis fungus HK-1. Herbal Drugs, Chin Tradit, 36 (2005) 1346.
Kumar, S., Yadav, S. P., Chandra, G., Sahu, D. S., Kumar, R., Maurya, P. S., ... & Ranjan, K. (2019). Effect of dietary supplementation of yeast (Saccharomyces cerevisiae) on performance and hemato-biochemical status of broilers.
Keshamma, E., Kumar, A., Jha, R., Amle, V. S., Dudhate, G. S., Patel, D., ... & Kumar, R. (2022). Breast Cancer Treatment Relying on Herbal Bioactive Components. Journal for Research in Applied Sciences and Biotechnology, 1(4), 105-115.
Sultana, A., Singh, M., Kumar, A., Kumar, R., Saha, P., Kumar, R. S., & Kumar, D. (2022). To Identify Drug-Drug Interaction in Cardiac Patients in Tertiary Care Hospitals. Journal for Research in Applied Sciences and Biotechnology, 1(3), 146-152.
Kumar, S., Keshamma, E., Trivedi, U., Janjua, D., Shaw, P., Kumar, R., ... & Saha, P. (2022). A meta analysis of different herbs (leaves, roots, stems) used in treatment of cancer cells. Journal for Research in Applied Sciences and Biotechnology, 1(3), 92-101.
Kumar, R., Saha, P., Keshamma, E., Sachitanadam, P., & Subramanian, M. (2022). Docking studies of some novel Hetrocyclic compound as Acat inhibitors: A meta analysis. Journal for Research in Applied Sciences and Biotechnology, 1(3), 33-41.
Kumar, R., Singh, A., & Painuly, N. (2022). Investigation of in-vitro anti-oxidant & anti-ulcer activity of polyherbal medicinal plants. Journal of Pharmaceutical Negative Results, 2077-2088.
Nyarko, R. O., Roopini, R., Raviteja, V., Awuchi, C. G., Kumar, R., Faller, E. M., ... & Saha, P. (2022). Novel Sars-CoV-2 Variants & Therapeutic Effects. Journal for Research in Applied Sciences and Biotechnology, 1(2), 25-34.
Pandey, M., Singh, A., Agnihotri, N., Kumar, R., Saha, P., Pandey, R. P., & Kumar, A. (2022). Clinical Pharmacology & Therapeutic uses of Diuretic Agents: A Review. Journal for Research in Applied Sciences and Biotechnology, 1(3), 11-20.
Amle, V. S., Rathod, D. A., Keshamma, E., Kumar, V., Kumar, R., & Saha, P. (2022). Bioactive Herbal Medicine Use for Eye Sight: A Meta Analysis. Journal for Research in Applied Sciences and Biotechnology, 1(3), 42-50.
Keshamma, E., Paswan, S. K., Kumar, R., Saha, P., Trivedi, U., Chourasia, A., & Otia, M. (2022). Alkaloid Based Chemical Constituents of Ocimum santum & Cinchona Bark: A Meta Analysis. Journal for Research in Applied Sciences and Biotechnology, 1(2), 35-42.
Singh, Y., Paswan, S. K., Kumar, R., Otia, M. K., Acharya, S., Kumar, D., & Keshamma, E. (2022). Plant & Its Derivative Shows Therapeutic Activity on Neuroprotective Effect. Journal for Research in Applied Sciences and Biotechnology, 1(2), 10-24.
Nalimu, F., Oloro, J., Kahwa, I., & Ogwang, P. E. (2021). Review on the phytochemistry and toxicological profiles of Aloe vera and Aloe ferox. Future Journal of Pharmaceutical Sciences, 7, 1-21.
Saha, P., Kumar, A., Bhanja, J., Shaik, R., Kawale, A. L., & Kumar, R. (2022). A Review of Immune Blockade Safety and Antitumor Activity of Dostarlimab Therapy in Endometrial Cancer. International Journal for Research in Applied Sciences and Biotechnology, 9(3), 201-209.
Kumar, R., Jain, A., Tripathi, A. K., & Tyagi, S. (2021, January). Covid-19 outbreak: An epidemic analysis using time series prediction model. In 2021 11th international conference on cloud computing, data science & engineering (Confluence) (pp. 1090-1094). IEEE.
Nyarko, R. O., Boateng, E., Kahwa, I., & Boateng, P. O. (2020). A comparison analysis on remdesivir, favipiravir, hydroxychloroquine, chloroquine and azithromycin in the treatment of corona virus disease 2019 (COVID-19)-A Review. World J. Pharm. Pharm. Sci, 9, 121-133.
Sahana, S., Kumar, R., Nag, S., Paul, R., Chatterjee, I., & Guha, N. (2020). A Review On Alzheimer Disease And Future Prospects.
Kumar, A., & Arya, R. K. (2020). Evolution Of Tolbutamide In The Treatment Of Diabetes Mellitus. Diabetes, 2, 10.
Purabisaha, R. K., Rawat, S. S. N., & Prakash, A. (2021). A Review On Novel Drug Delivery System.
Nyarko, R. O., Kumar, R., Sharma, S., Chourasia, A., Roy, A., & Saha, P. (2022). Antibacterial Activity of Herbal Plant-Tinospora Cordifolia And Catharnthus Roseus.
Saha, P., Nyarko, R. O., Lokare, P., Kahwa, I., Boateng, P. O., & Asum, C. (2022). Effect of Covid-19 in Management of Lung Cancer Disease: A Review. Asian Journal of Pharmaceutical Research and Development, 10(3), 58-64.
Kumar, R., & Dubey, A. (2020). Phytochemical Investication And Heptoprotective Evalution Acacia Rubica Extract Isonized And Paracetamol Indused Animal Toxicity. Turkish Journal of Physiotherapy and Rehabilitation, 32(3), 65-69.
Raj, A., Tyagi, S., Kumar, R., Dubey, A., & Hourasia, A. C. (2021). Effect of isoproterenol and thyroxine in herbal drug used as cardiac hypertrophy. Journal of Cardiovascular Disease Research, 204-217.
Kumar, R., Verma, H., Singhvi, N., Sood, U., Gupta, V., Singh, M., ... & Lal, R. (2020). Comparative genomic analysis of rapidly evolving SARS-CoV-2 reveals mosaic pattern of phylogeographical distribution. Msystems, 5(4), e00505-20.
Kumar, R., Saha, P., Nyarko, R. O., Kahwn, I., Boateng, E. A., Boateng, P. O., ... & Bertram, A. (2021). Role of Cytokines and Vaccines in Break through COVID 19 Infections. Journal of Pharmaceutical Research International, 33(60B), 2544-2549.
Saha, P., Kumar, R., Nyarko, R. O., Kahwa, I., & Owusu, P. (2021). Herbal Secondary Metabolite For Gastro-Protective Ulcer Activity With Api Structures.
Sahana, S. (2020). Purabi saha, Roshan kumar, Pradipta das, Indranil Chatterjee, Prasit Roy, Sk Abdur Rahamat. A Review of the 2019 Corona virus (COVID-19) World Journal of Pharmacy and Pharmaceutical science, 9(9), 2367-2381.
Kumar, R., Saha, P., Kumar, Y., Sahana, S., Dubey, A., & Prakash, O. (2020). A Review on Diabetes Mellitus: Type1 & Type2. World Journal of Pharmacy and Pharmaceutical Sciences, 9(10), 838-850.
Daharia, A., Jaiswal, V. K., Royal, K. P., Sharma, H., Joginath, A. K., Kumar, R., & Saha, P. (2022). A Comparative review on ginger and garlic with their pharmacological Action. Asian Journal of Pharmaceutical Research and Development, 10(3), 65-69.
Kumar, R., Sood, U., Gupta, V., Singh, M., Scaria, J., & Lal, R. (2020). Recent advancements in the development of modern probiotics for restoring human gut microbiome dysbiosis. Indian journal of microbiology, 60, 12-25.
Awuchi, C. G., Amagwula, I. O., Priya, P., Kumar, R., Yezdani, U., & Khan, M. G. (2020). Aflatoxins in foods and feeds: A review on health implications, detection, and control. Bull. Environ. Pharmacol. Life Sci, 9, 149-155.
Yadav, A. N., Verma, P., Kumar, R., Kumar, V., & Kumar, K. (2017). Current applications and future prospects of eco-friendly microbes. EU Voice, 3(1), 21-22.
Kumar, R., Saha, P., Lokare, P., Datta, K., Selvakumar, P., & Chourasia, A. (2022). A Systemic Review of Ocimum sanctum (Tulsi): Morphological Characteristics, Phytoconstituents and Therapeutic Applications. International Journal for Research in Applied Sciences and Biotechnology, 9(2), 221-226.
Kumar, R., & Saha, P. (2022). A review on artificial intelligence and machine learning to improve cancer management and drug discovery. International Journal for Research in Applied Sciences and Biotechnology, 9(3), 149-156.
Mirzaie, A., Halaji, M., Dehkordi, F. S., Ranjbar, R., & Noorbazargan, H. (2020). A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19). Complementary therapies in clinical practice, 40, 101214.
Dubey, A., Yadav, P., Verma, P., & Kumar, R. (2022). Investigation of Proapoptotic Potential of Ipomoea carnea Leaf Extract on Breast Cancer Cell Line. Journal of Drug Delivery and Therapeutics, 12(1), 51-55.
Umama, Y., Venkatajah, G., Shourabh, R., Kumar, R., Verma, A., Kumar, A., & Gayoor, M. K. (2019). Topic-The scenario of pharmaceuticals and development of microwave as; sisted extraction technique. World J Pharm Pharm Sci, 8(7), 1260-1271.
Bind, A., Das, S., Singh, V. D., Kumar, R., Chourasia, A., & Saha, P. (2020). Natural Bioactives For The Potential Management Of Gastric Ulceration. Turkish Journal of Physiotherapy and Rehabilitation, 32(3), 221-226.
Zhang, D., Zhang, B., Lv, J. T., Sa, R. N., Zhang, X. M., & Lin, Z. J. (2020). The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence. Pharmacological research, 157, 104882.
Fang, Y., Yang, C., Yu, Z., Li, X., Mu, Q., Liao, G., & Yu, B. (2021). Natural products as LSD1 inhibitors for cancer therapy. Acta Pharmaceutica Sinica B, 11(3), 621-631.
Mousavi, S. S., Karami, A., Haghighi, T. M., Tumilaar, S. G., Fatimawali, Idroes, R., ... & Capasso, R. (2021). In silico evaluation of Iranian medicinal plant phytoconstituents as inhibitors against main protease and the receptor-binding domain of SARS-CoV-2. Molecules, 26(18), 5724.
Zhu, Y., Li, J., & Pang, Z. (2021). Recent insights for the emerging COVID-19: Drug discovery, therapeutic options and vaccine development. Asian Journal of Pharmaceutical Sciences, 16(1), 4-23.
Mesri, M., Esmaeili Saber, S. S., Godazi, M., Roustaei Shirdel, A., Montazer, R., Koohestani, H. R., ... & Azizi, N. (2021). The effects of combination of Zingiber officinale and Echinacea on alleviation of clinical symptoms and hospitalization rate of suspected COVID-19 outpatients: a randomized controlled trial. Journal of Complementary and Integrative Medicine, 18(4), 775-781.
Yao, Q., Zhu, X., Han, M., Chen, C., Li, W., Bai, H., & Ning, K. (2022). Decoding herbal materials of TCM preparations with the multi-barcode sequencing approach. Scientific Reports, 12(1), 5988.
Dong, J., Wu, H., Zhou, D., Li, K., Zhang, Y., Ji, H., ... & Liu, Z. (2021). Application of big data and artificial intelligence in COVID-19 prevention, diagnosis, treatment and management decisions in China. Journal of Medical Systems, 45(9), 84.
Shahrajabian, M. H., Sun, W., & Cheng, Q. (2021). Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2. Human Vaccines & Immunotherapeutics, 17(1), 62-83.
Hu, S., Wang, J., Zhang, Y., Bai, H., Wang, C., Wang, N., & He, L. (2021). Three salvianolic acids inhibit 2019‐nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2. Journal of medical virology, 93(5), 3143-3151.
Chen, K., & Chen, H. (2020). Traditional Chinese medicine for combating COVID-19. Frontiers of Medicine, 14, 529-532.
Chapman, R. L., & Andurkar, S. V. (2022). A review of natural products, their effects on SARS-CoV-2 and their utility as lead compounds in the discovery of drugs for the treatment of COVID-19. Medicinal Chemistry Research, 31(1), 40-51.
Bastani, S., Vahedian, V., Rashidi, M., Mir, A., Mirzaei, S., Alipourfard, I., ... & Akbarzadeh, M. (2022). An evaluation on potential anti-oxidant and anti-inflammatory effects of Crocin. Biomedicine & Pharmacotherapy, 153, 113297.
Li, W., Yang, X., Chen, B., Zhao, D., Wang, H., Sun, M., ... & Yang, W. (2021). Ultra-high performance liquid chromatography/ion mobility time-of-flight mass spectrometry-based untargeted metabolomics combined with quantitative assay unveiled the metabolic difference among the root, leaf, and flower bud of Panax notoginseng. Arabian Journal of Chemistry, 14(11), 103409.
Han, L., Wei, X. X., Zheng, Y. J., Zhang, L. L., Wang, X. M., Yang, H. Y., ... & Tong, X. L. (2020). Potential mechanism prediction of Cold-Damp Plague Formula against COVID-19 via network pharmacology analysis and molecular docking. Chinese medicine, 15, 1-16.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.